Target Validation Information
TTD ID T20401
Target Name Carbonic anhydrase II (CA-II)
Type of Target
Successful
Drug Potency against Target Ethinamate Drug Info IC50 = 0.6~2.5 g/ml [65]
Drug Info Ki = 25 nM [19]
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate Drug Info Ki = 1020 nM [22]
(2-bromophenyl)difluoromethanesulfonamide Drug Info Ki = 112 nM [19]
(4-bromophenyl)difluoromethanesulfonamide Drug Info Ki = 98 nM [19]
1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide Drug Info Ki = 77 nM [57]
1,4-phenylene disulfamate Drug Info Ki = 643 nM [37]
1-(3,4-dichlorophenyl)-3-hydroxyurea Drug Info Ki = 310 nM [23]
1-acetamido-5-sulfonamidoindane Drug Info Ki = 186 nM [21]
1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide Drug Info Ki = 80 nM [57]
1-cyclohexylamido-5-sulfonamidoindane Drug Info Ki = 32 nM [21]
1-pentafluorophenylamido-5-sulfonamidoindane Drug Info Ki = 490 nM [21]
1-pentenyl-4-(aminosulfonyl)benzoate Drug Info Ki = 7.7 nM [20]
1-valproylamido-5-sulfonamidoindane Drug Info Ki = 1.2 nM [21]
2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide Drug Info Ki = 133 nM [18]
2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide Drug Info Ki = 230 nM [18]
2,3-dihydro-1H-indene-5-sulfonamide Drug Info Ki = 52 nM [6]
2,4-dichloro-5-sulfamoylbenzoic acid Drug Info IC50 = 18000 nM [51]
2,4-Disulfamyltrifluoromethylaniline Drug Info Ki = 63 nM [49]
2,6-di-t-butylphenol Drug Info Ki = 510 nM [39]
2,6-di-tert-butyl-4-methoxyphenol Drug Info Ki = 420 nM [39]
2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide Drug Info Ki = 4800 nM [27]
2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide Drug Info Ki = 6100 nM [27]
2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide Drug Info Ki = 4700 nM [27]
2-(4-hydroxybenzylideneamino)ethanesulfonamide Drug Info Ki = 236 nM [48]
2-(4-tert-butylbenzylideneamino)ethanesulfonamide Drug Info Ki = 8.6 nM [48]
2-(benzylideneamino)ethanesulfonamide Drug Info Ki = 160 nM [48]
2-(benzyloxyamino)-N-hydroxyhexanamide Drug Info Ki = 7800 nM [27]
2-(N''-Acetyl-hydrazino)-benzenesulfonamide Drug Info Ki = 264 nM [14]
2-acetamido-5-sulfonamidoindane Drug Info Ki = 1 nM [21]
2-Acetylamino-indan-5-sulfonic acid hydrate Drug Info Ki = 65 nM [6]
2-Amino-benzenesulfonamide Drug Info Ki = 295 nM [49]
2-Amino-indan-5-sulfonic acid Drug Info Ki = 84 nM [6]
2-butylamido-5-sulfonamidoindane Drug Info Ki = 7.5 nM [21]
2-cyclohexylamido-5-sulfonamidoindane Drug Info Ki = 118 nM [21]
2-ethylamido-5-sulfonamidoindane Drug Info Ki = 10 nM [21]
2-Hydrazinocarbonyl-benzenesulfonamide Drug Info Ki = 338 nM [14]
2-hydrazinylbenzenesulfonamide Drug Info Ki = 125 nM [66]
2-Hydroxycinnamic acid Drug Info Ki = 9200 nM [61]
2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide Drug Info Ki = 16 nM [30]
2-methoxyestradiol-17-O-sulfamate Drug Info IC50 = 526 nM [28]
2-methoxyestrrone-3-O-sulfamate Drug Info IC50 = 376 nM [28]
2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide Drug Info Ki = 87 nM [7]
2-nonylamido-5-sulfonamidoindane Drug Info Ki = 128 nM [21]
2-oxo-2H-thiochromene-3-carboxylic acid Drug Info Ki = 7800 nM [50]
2-pentafluorophenylamido-5-sulfonamidoindane Drug Info Ki = 6.7 nM [21]
2-propylamido-5-sulfonamidoindane Drug Info Ki = 46 nM [21]
2-Sulfamoyl-benzoic acid methyl ester Drug Info Ki = 420 nM [14]
2-valproylamido-5-sulfonamidoindane Drug Info Ki = 0.9 nM [21]
3-((4-aminophenyl)diazenyl)benzenesulfonamide Drug Info Ki = 88 nM [46]
3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide Drug Info Ki = 106 nM [46]
3-(3-Phenyl-ureido)-benzenesulfonamide Drug Info Ki = 150 nM [18]
3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide Drug Info Ki = 106 nM [46]
3-(4-sulfamoylphenyl)propanoic acid Drug Info Ki = 495 nM [49]
3-Amino-benzenesulfonamide Drug Info Ki = 240 nM [11]
3-bromophenyl-difluoromethanesulfonamide Drug Info Ki = 565 nM [19]
3-Chloro-4-hydrazino-benzenesulfonamide Drug Info Ki = 76 nM [14]
3-Fluoro-4-hydrazino-benzenesulfonamide Drug Info Ki = 51 nM [14]
3-hydroxy-2-methoxybenzaldehyde Drug Info Ki = 1250 nM [39]
3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide Drug Info Ki = 27 nM [24]
3-Nitro-benzenesulfonamide Drug Info IC50 = 410 nM [4]
3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide Drug Info Ki = 31 nM [44]
3-phenylprop-1-enylboronic acid Drug Info Ki = 18100 nM [42]
4,4'-thiodipyridine-3-sulfonamide Drug Info Ki = 65 nM [55]
4,6-Dinitro salicylic acid Drug Info Ki = 5450 nM [35]
4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide Drug Info Ki = 665 nM [46]
4-((benzylideneamino)methyl)benzenesulfonamide Drug Info Ki = 38.5 nM [48]
4-(2-AMINOETHYL)BENZENESULFONAMIDE Drug Info Ki = 160 nM [17]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide Drug Info Ki = 33 nM [49]
4-(2-Hydroxy-ethyl)-benzenesulfonamide Drug Info Ki = 125 nM [60]
4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide Drug Info Ki = 80.4 nM [55]
4-(2-Phenylacetamido)-3-bromobenzenesulfonamide Drug Info Ki = 395 nM [45]
4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide Drug Info Ki = 58 nM [45]
4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide Drug Info Ki = 61 nM [45]
4-(2-Phenylacetamido)benzenesulfonamide Drug Info Ki = 107 nM [45]
4-(2-Phenylacetamidoethyl)benzenesulfonamide Drug Info Ki = 67 nM [45]
4-(2-Phenylacetamidomethyl)benzenesulfonamide Drug Info Ki = 54 nM [45]
4-(2-Propynylthio)pyridine-3-sulfonamide Drug Info Ki = 108 nM [55]
4-(2-Pyridin-2-ylacetamido)benzenesulfonamide Drug Info Ki = 69 nM [45]
4-(2-Pyridin-4-ylacetamido)benzenesulfonamide Drug Info Ki = 74 nM [45]
4-(4-Cyanophenoxy)-3-pyridinesulfonamide Drug Info Ki = 94.5 nM [55]
4-(4-Fluorophenoxy)-3-pyridinesulfonamide Drug Info Ki = 94.4 nM [55]
4-(4-hydroxy-benzylideneamino)-benzenesulfonamide Drug Info Ki = 701.8 nM [48]
4-(4-hydroxybenzylideneamino)benzoic acid Drug Info Ki = 200.5 nM [48]
4-(4-tert-butylbenzylideneamino)benzoic acid Drug Info Ki = 184.5 nM [48]
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide Drug Info Ki = 140 nM [55]
4-(Allylamino)-3-pyridinesulfonamide Drug Info Ki = 133 nM [55]
4-(benzylideneamino)benzenesulfonamide Drug Info Ki = 21.4 nM [48]
4-(benzylideneamino)benzoic acid Drug Info Ki = 123.2 nM [48]
4-(Carbamolymethylthio)pyridine-3-sulfonamide Drug Info Ki = 131 nM [55]
4-(Cyanomethylthio)pyridine-3-sulfonamide Drug Info Ki = 91.1 nM [55]
4-(hydroxymethyl)benzenesulfonamide Drug Info Ki = 80 nM [49]
4-(Methylhydrazino)-3-pyridinesulfonamide Drug Info Ki = 87.2 nM [55]
4-(N-Methyl-hydrazino)-benzenesulfonamide Drug Info Ki = 300 nM [9]
4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide Drug Info Ki = 84.5 nM [55]
4-(Quinolinoxy)-3-pyridinesulfonamide Drug Info Ki = 105 nM [55]
4-Amino-3-bromo-benzenesulfonamide Drug Info Ki = 40 nM [49]
4-Amino-3-chloro-benzenesulfonamide Drug Info Ki = 110 nM [49]
4-Amino-3-fluoro-benzenesulfonamide Drug Info Ki = 60 nM [60]
4-Amino-3-iodo-benzenesulfonamide Drug Info Ki = 70 nM [49]
4-amino-6-chlorobenzene-1,3-disulfonamide Drug Info Ki = 75 nM [60]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info Ki = 46 nM [49]
4-azidobenzenesulfonamide Drug Info Ki = 47 nM [34]
4-Benzenesulfonylamino-benzenesulfonamide Drug Info Ki = 49 nM [18]
4-Benzythiopyridine-3-sulfonamide Drug Info Ki = 9.9 nM [55]
4-bromophenylboronic acid Drug Info Ki = 7000 nM [42]
4-butylphenylboronic acid Drug Info Ki = 8700 nM [42]
4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide Drug Info Ki = 7.5 nM [6]
4-CYANOPHENOL Drug Info Ki = 108 nM [32]
4-Ethoxy-3-pyridinesulfonamide Drug Info Ki = 76.7 nM [55]
4-ethynyl benzene sulfonamide Drug Info Ki = 5.1 nM [29]
4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide Drug Info Ki = 100 nM [37]
4-Hydrazino-3-pyridinesulfonamide Drug Info Ki = 85.6 nM [55]
4-Hydrazino-benzenesulfonamide Drug Info Ki = 300 nM [38]
4-isothiocyanatobenzenesulfonamide Drug Info Ki = 185 nM [3]
4-Methanesulfonylamino-benzenesulfonamide Drug Info Ki = 64 nM [18]
4-Methoxy-3-pyridinesulfonamide Drug Info Ki = 93.8 nM [55]
4-methoxyphenylboronic acid Drug Info Ki = 7900 nM [42]
4-methoxyphenylsulfamide Drug Info Ki = 18800 nM [22]
4-Methylamino-benzenesulfonamide Drug Info Ki = 240 nM [9]
4-methylphenyl-difluoromethanesulfonamide Drug Info Ki = 348 nM [19]
4-Methylthiopyridine-3-sulfonamide Drug Info Ki = 40.1 nM [55]
4-Nitro-benzenesulfonamide Drug Info IC50 = 400 nM [4]
4-nitrophenyl phosphate Drug Info IC50 = 63 nM [63]
4-nitrophenyl-difluoromethanesulfonamide Drug Info Ki = 113 nM [19]
4-nitrophenylsulfamide Drug Info Ki = 1740 nM [22]
4-phenoxyphenylboronic acid Drug Info Ki = 11500 nM [42]
4-Thiocyanato-benzenesulfonamide Drug Info IC50 = 3600 nM [4]
4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide Drug Info Ki = 53 nM [45]
4-[2-(2-Thienyl)acetamido]benzenesulfonamide Drug Info Ki = 50 nM [45]
4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide Drug Info Ki = 75 nM [18]
5-Amino-[1,3,4]thiadiazole-2-thiol Drug Info Ki = 9200 nM [15]
5-Chlorosalicylic Acid Drug Info Ki = 1270 nM [35]
5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one Drug Info Ki = 14600 nM [58]
6-(aminomethyl)-2H-chromen-2-one Drug Info Ki = 18500 nM [50]
6-(hydroxymethyl)-2H-chromen-2-one Drug Info Ki = 19200 nM [50]
6-Amino-benzothiazole-2-sulfonic acid amide Drug Info Ki = 9 nM [1]
6-Hydroxy-benzothiazole-2-sulfonic acid amide Drug Info Ki = 30 nM [38]
6-hydroxybenzo[d][1,3]oxathiol-2-one Drug Info IC50 = 1770 nM [31]
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 13400 nM [50]
6-methyl-2-oxo-2H-chromene-3-carboxylic acid Drug Info Ki = 9100 nM [50]
6-Nitro-benzothiazole-2-sulfonic acid amide Drug Info IC50 = 250 nM [4]
ACETYLSULFANILAMIDE Drug Info Ki = 246 nM [18]
Allyl 4-(aminosulfonyl)benzoate Drug Info Ki = 8.6 nM [20]
Aminobenzolamide derivative Drug Info Ki = 0.9 nM [5]
Azide Drug Info Ki = 1.5 nM [2]
BENZOLAMIDE Drug Info Ki = 9 nM [49]
Benzothiazole-2-sulfonic acid amide Drug Info Ki = 30 nM [10]
Beta-naphthylboronic acid Drug Info Ki = 6000 nM [42]
Biphenyl-4-ylboronic acid Drug Info Ki = 4500 nM [42]
BUTYLATEDHYDROXYTOLUENE Drug Info Ki = 630 nM [39]
Carzenide Drug Info Ki = 151 nM [20]
CATECHIN Drug Info Ki = 1840 nM [61]
CATECHOL Drug Info Ki = 9900 nM [53]
CHLORIDE Drug Info Ki = 200 nM [2]
CL-5343 Drug Info Ki = 7400 nM [62]
COUMARIN Drug Info Ki = 9200 nM [64]
Coumate Drug Info Ki = 21 nM [33]
Curcumin Drug Info Ki = 380 nM [61]
Decane-1,10-diyl disulfamate Drug Info Ki = 24.5 nM [47]
Decyl sulfamate Drug Info Ki = 0.7 nM [47]
Di(2,6-di-t-butylphenol) Drug Info Ki = 290 nM [39]
Di(2,6-diisopropylphenol) Drug Info Ki = 1870 nM [39]
Di(2,6-dimethylphenol) Drug Info Ki = 4050 nM [39]
ELLAGIC ACID Drug Info Ki = 2180 nM [53]
EMATE Drug Info IC50 = 42 nM [26]
FERULIC ACID Drug Info Ki = 2400 nM [53]
GALLICACID Drug Info Ki = 2250 nM [53]
GUAIACOL Drug Info Ki = 2940 nM [39]
INDISULAM Drug Info Ki = 15 nM [57]
IODIDE Drug Info Ki = 26 nM [2]
Methyl 4-(4-hydroxybenzylideneamino)benzoate Drug Info Ki = 141.5 nM [48]
Methyl 4-(4-tert-butylbenzylideneamino)benzoate Drug Info Ki = 158.4 nM [48]
MMI270 Drug Info Ki = 8600 nM [27]
N-(1-benzofuran-3-ylmethyl)sulfamide Drug Info IC50 = 7100 nM [43]
N-(4-cyanophenyl)sulfamide Drug Info Ki = 16 nM [16]
N-(4-Sulfamoyl-phenyl)-benzamide Drug Info Ki = 37 nM [18]
N-(4-Sulfamoyl-phenyl)-butyramide Drug Info Ki = 227 nM [18]
N-(4-Sulfamoyl-phenyl)-isobutyramide Drug Info Ki = 258 nM [18]
N-(4-Sulfamoyl-phenyl)-propionamide Drug Info Ki = 232 nM [18]
N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide Drug Info Ki = 5 nM
N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 950 nM [36]
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide Drug Info Ki = 8800 nM [15]
N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 870 nM [36]
N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide Drug Info Ki = 900 nM [36]
N-(pentafluorophenyl)sulfamide Drug Info Ki = 32 nM [16]
N-(phosphonacetyl)-L-aspartate Drug Info Ki = 7800 nM [12]
N-1,3,4-thiadiazol-2-ylsulfamide Drug Info Ki = 970 nM [36]
N-hydroxysulfamide Drug Info Ki = 566 nM [56]
N-propynyl amidebenzenesulphonide Drug Info Ki = 47 nM [25]
N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide Drug Info IC50 = 3700 nM [43]
N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide Drug Info IC50 = 8400 nM [43]
N-[4-(trifluoromethyl)phenyl]sulfamide Drug Info Ki = 7000 nM [16]
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info Ki = 1130 nM [36]
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide Drug Info Ki = 920 nM [36]
NITRATE Drug Info Ki = 35 nM [2]
NSC-654077 Drug Info Ki = 4975 nM [30]
Octane-1,8-diyl disulfamate Drug Info Ki = 14.6 nM [47]
Octyl sulfamate Drug Info Ki = 2.7 nM [47]
P-Coumaric Acid Drug Info Ki = 980 nM [53]
P-toluenesulfonamide Drug Info Ki = 320 nM [49]
P-tolylboronic acid Drug Info Ki = 10800 nM [42]
PARABEN Drug Info Ki = 870 nM [53]
PARAOXON Drug Info IC50 = 59 nM [63]
Pentane-1,5-diamine Drug Info Ki = 11000 nM [59]
Pentanoic acid (4-sulfamoyl-phenyl)-amide Drug Info Ki = 214 nM [18]
Phenethylboronic acid Drug Info Ki = 17900 nM [42]
PHENOL Drug Info Ki = 5500 nM [61]
Phenoxyarsonous acid Drug Info Ki = 49.2 nM [2]
Phenyl Boronic acid Drug Info Ki = 23.1 nM [2]
Phenyl-phosphonic acid Drug Info Ki = 99 nM [12]
PHENYLDIFLUOROMETHANESULFONAMIDE Drug Info Ki = 156 nM [19]
PHENYLMETHANESULFONAMIDE Drug Info Ki = 645 nM [19]
PHENYLSULFAMATE Drug Info Ki = 36 nM [22]
PHENYLSULFAMIDE Drug Info Ki = 8020 nM [22]
PRONTOCIL Drug Info Ki = 13000 nM [46]
Prop-2-ynyl 4-sulfamoylbenzoate Drug Info Ki = 45 nM [25]
Quinoline-8-sulfonamide Drug Info Ki = 125 nM [37]
RESORCINOL Drug Info Ki = 7700 nM [32]
SACCHARIN Drug Info Ki = 5959 nM [60]
Salicyclic acid Drug Info Ki = 7100 nM [32]
Sodium 2,3,5,6-tetrafluorobenzoate Drug Info Ki = 6000 nM [41]
SODIUM PERFLUOROHEXANESULFONAMIDE Drug Info IC50 = 122 nM [52]
Sodium trithiocarbonate Drug Info Ki = 8800 nM [40]
STX-140 Drug Info IC50 = 379 nM [28]
SULFAMATE Drug Info Ki = 0.39 nM [2]
Sulfamic acid 12-sulfamoyloxy-dodecyl ester Drug Info Ki = 84.2 nM [8]
Sulfamic acid 16-sulfamoyloxy-hexadecyl ester Drug Info Ki = 563 nM [8]
Sulfamic acid 3-sulfamoyloxy-phenyl ester Drug Info Ki = 9.4 nM [8]
Sulfamic acid 4-sulfamoyloxy-butyl ester Drug Info Ki = 15 nM [8]
Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester Drug Info Ki = 643 nM [8]
Sulfamic acid 6-sulfamoyloxy-hexyl ester Drug Info Ki = 8.3 nM [8]
Sulfamic acid 7-sulfamoyloxy-heptyl ester Drug Info Ki = 8 nM [8]
Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester Drug Info IC50 = 280 nM [13]
Sulfamic acid chroman-2-ylmethyl ester Drug Info IC50 = 130 nM [13]
SULFAMIDE Drug Info Ki = 1.13 nM [2]
Sulfamylon Drug Info Ki = 170 nM [54]
Syringic Acid Drug Info Ki = 3190 nM [53]
References
REF 1 Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides co... J Med Chem. 1999 Jul 15;42(14):2641-50.
REF 2 Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9.
REF 3 Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. J Med Chem. 2004 Oct 7;47(21):5224-9.
REF 4 Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5703-7.
REF 5 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides d... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.
REF 6 Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6.
REF 7 Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic... Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72.
REF 8 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.
REF 9 Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglauc... Bioorg Med Chem Lett. 2005 Feb 15;15(4):963-9.
REF 10 Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6.
REF 11 Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1149-54.
REF 12 Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1683-6.
REF 13 Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. J Med Chem. 2005 Mar 24;48(6):1941-7.
REF 14 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamide... J Med Chem. 2005 Mar 24;48(6):2121-5.
REF 15 Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-th... Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.
REF 16 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxy... Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8.
REF 17 Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-media... J Med Chem. 2005 Jul 28;48(15):4834-41.
REF 18 Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4862-6.
REF 19 Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6.
REF 20 Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5429-33.
REF 21 Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9.
REF 22 Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. J Med Chem. 2006 Jun 15;49(12):3496-500.
REF 23 N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4316-20.
REF 24 Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J Med Chem. 2006 Sep 7;49(18):5544-51.
REF 25 A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". J Med Chem. 2006 Nov 2;49(22):6539-48.
REF 26 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem. 2006 Dec 28;49(26):7683-96.
REF 27 Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with su... Bioorg Med Chem. 2007 Mar 15;15(6):2298-311.
REF 28 Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. J Med Chem. 2008 Mar 13;51(5):1295-308.
REF 29 Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. J Med Chem. 2008 Mar 27;51(6):1945-53.
REF 30 Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem. 2008 Jun 12;51(11):3051-6.
REF 31 Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors Bioorg Med Chem Lett. 2008 Jul 15;18(14):3938-41.
REF 32 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
REF 33 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-r... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6.
REF 34 Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4624-7.
REF 35 In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem. 2008 Oct 15;16(20):9101-5.
REF 36 Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes ... Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5.
REF 37 Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorg Med Chem. 2009 Jan 15;17(2):553-7.
REF 38 Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
REF 39 Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem. 2009 Apr 15;17(8):3207-11.
REF 40 Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1855-7.
REF 41 Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with ali... Bioorg Med Chem. 2009 Apr 1;17(7):2654-7.
REF 42 Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett. 2009 May 15;19(10):2642-5.
REF 43 Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into huma... J Med Chem. 2009 Dec 10;52(23):7528-36.
REF 44 Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem. 2009 Jul 9;52(13):4063-7.
REF 45 Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inh... Bioorg Med Chem. 2009 Jul 15;17(14):4894-9.
REF 46 Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesul... Bioorg Med Chem Lett. 2009 Sep 1;19(17):4929-32.
REF 47 Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-bi... J Med Chem. 2009 Oct 8;52(19):5990-8.
REF 48 Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6014-7.
REF 49 Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, ... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6649-54.
REF 50 Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
REF 51 Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Bioorg Med Chem. 2010 Jan 15;18(2):930-8.
REF 52 Synthesis and investigation of inhibition effect of fluorinated sulfonamide derivatives on carbonic anhydrase. Eur J Med Chem. 2010 Mar;45(3):1225-9.
REF 53 Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
REF 54 Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem. 2010 Apr 8;53(7):2913-26.
REF 55 Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associa... Eur J Med Chem. 2010 Jun;45(6):2396-404.
REF 56 Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5.
REF 57 Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the... Eur J Med Chem. 2010 Sep;45(9):3656-61.
REF 58 A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies. Bioorg Med Chem. 2010 Jun 15;18(12):4468-74.
REF 59 Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
REF 60 Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorg Med Chem. 2010 Aug 1;18(15):5498-503.
REF 61 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
REF 62 Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. Eur J Med Chem. 2010 Nov;45(11):4769-73.
REF 63 Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of - but not of -, - and -carbonic anhydrases. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6208-12.
REF 64 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and X... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8.
REF 65 The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol. 2005;45:529-64.
REF 66 Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bioorg Med Chem. 2009 Jul 15;17(14):5054-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.